Irene Mattavelli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Beyond the slope: prognostic utility of the VE/VCO2 intercept in chronic heart failure.
Journal: Open heart
Published: June 01, 2026
A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification.
Journal: European journal of preventive cardiology
Published: April 28, 2026
Beyond mitral regurgitation reduction: Divergent hemodynamic and structural responses to transcatheter edge-to-edge repair in primary and secondary mitral regurgitation.
Journal: International journal of cardiology
Published: April 19, 2026
Posture matters: how body position shapes cardiopulmonary response to maximal exercise testing.
Journal: American journal of physiology. Heart and circulatory physiology
Published: April 17, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: April 09, 2026
Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study.
Journal: ESC heart failure
Published: February 01, 2026
Gliflozins in Practice: Real-Life Use of Dapagliflozin and Empagliflozin in HFrEF Versus Clinical Trial Data.
Journal: Diagnostics (Basel, Switzerland)
Published: January 30, 2026
Method validation of cardiopulmonary exercise testing: intra- and inter-device comparisons across four metabolic carts.
Journal: European heart journal. Quality of care & clinical outcomes
Published: January 14, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O2-pulse in hypertrophic cardiomyopathy.
Journal: Scientific reports
Published: December 09, 2025
Peripheral oxygenation in heart failure patients with periodic breathing: insights from NIRS.
Journal: European heart journal. Acute cardiovascular care
Published: July 15, 2025
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF).
Journal: International journal of molecular sciences
Published: June 06, 2025
Last Updated: 09/26/2026